Molecular Docking and Pharmacokinetic Profiling of Nab-paclitaxel as Advanced Chemotherapeutic Agent Against HER-2 Positive Breast Cancer Patients by Mangilit, Nicole Jacob DJ, Arkoncel, Ana Beatrice S., Baylon, Karyll Mikaela DL, Eslabra, Jan Marnyle V., De Borja, John Lawrence D., Nakama, Johji G., Esmalla, Maria Salvacion A., Labrador, Alexis M., Paulin, John P., Santiago-Bautista, Myla R.

Get full text